AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of ARS 492.68 trillion. The enterprise value is 581.84 trillion.

Market Cap	492.68T
Enterprise Value	581.84T

Important Dates

The next confirmed earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	Apr 15, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	75.33%
Float	1.77B

Valuation Ratios

The trailing PE ratio is 81.09 and the forward PE ratio is 13.88.

PE Ratio	81.09
Forward PE	13.88
PS Ratio	5.55
PB Ratio	-105.16
P/TBV Ratio	n/a
P/FCF Ratio	19.05
P/OCF Ratio	17.84
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.91, with an EV/FCF ratio of 22.50.

EV / Earnings	95.77
EV / Sales	6.74
EV / EBITDA	13.91
EV / EBIT	19.53
EV / FCF	22.50

Financial Position

The company has a current ratio of 0.67

Current Ratio	0.67
Quick Ratio	0.41
Debt / Equity	n/a
Debt / EBITDA	2.31
Debt / FCF	3.84
Interest Coverage	7.30

Financial Efficiency

Return on equity (ROE) is 6,225.00% and return on invested capital (ROIC) is 22.49%.

Return on Equity (ROE)	6,225.00%
Return on Assets (ROA)	9.81%
Return on Invested Capital (ROIC)	22.49%
Return on Capital Employed (ROCE)	23.29%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.56B
Profits Per Employee	106.59M
Employee Count	57,000
Asset Turnover	0.45
Inventory Turnover	3.80

Taxes

In the past 12 months, AbbVie has paid 3.43 trillion in taxes.

Income Tax	3.43T
Effective Tax Rate	35.83%

Stock Price Statistics

The stock price has increased by +32.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+32.86%
50-Day Moving Average	31,792.80
200-Day Moving Average	31,655.75
Relative Strength Index (RSI)	39.99
Average Volume (20 Days)	1,653

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.07

Income Statement

In the last 12 months, AbbVie had revenue of ARS 88.77 trillion and earned 6.08 trillion in profits. Earnings per share was 3,425.30.

Revenue	88.77T
Gross Profit	63.58T
Operating Income	30.65T
Pretax Income	9.57T
Net Income	6.08T
EBITDA	42.46T
EBIT	30.65T
Earnings Per Share (EPS)	3,425.30

Balance Sheet

The company has 7.63 trillion in cash and 99.28 trillion in debt, giving a net cash position of -91,645.75 billion.

Cash & Cash Equivalents	7.63T
Total Debt	99.28T
Net Cash	-91,645.75B
Net Cash Per Share	n/a
Equity (Book Value)	-4,685.12B
Book Value Per Share	-2,684.62
Working Capital	-20,649.07B

Cash Flow

In the last 12 months, operating cash flow was 27.62 trillion and capital expenditures -1,762.00 billion, giving a free cash flow of 25.86 trillion.

Operating Cash Flow	27.62T
Capital Expenditures	-1,762.00B
Depreciation & Amortization	11.54T
Net Borrowing	-430.98B
Free Cash Flow	25.86T
FCF Per Share	n/a

Margins

Gross margin is 71.62%, with operating and profit margins of 34.52% and 6.91%.

Gross Margin	71.62%
Operating Margin	34.52%
Pretax Margin	10.79%
Profit Margin	6.91%
EBITDA Margin	47.83%
EBIT Margin	34.52%
FCF Margin	29.13%

Dividends & Yields

This stock pays an annual dividend of 662.53, which amounts to a dividend yield of 2.21%.

Dividend Per Share	662.53
Dividend Yield	2.21%
Dividend Growth (YoY)	58.83%
Years of Dividend Growth	5
Payout Ratio	275.84%
Buyback Yield	n/a
Shareholder Yield	2.21%
Earnings Yield	1.23%
FCF Yield	5.25%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.26 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.26
Piotroski F-Score	8